Article
TGF-β1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Oct 2013
Li Weixing, Wu Han, Song Chao
Abstract excerpt
Many studies have reported the role of transforming growth factor-β1 (TGF-β1) -509C/T or +869T/C polymorphism with hepatocellular carcinoma (HCC) risk. However, these studies have yielded conflicting results. Hence, we performed this meta-analysis to investigate the association between TGF-β1 -509C/T or +869T/C polymorphism and HCC. A total of 11 studies including 2,577 HCC cases and 4,107 controls were included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
